Epilepsy and psychiatry: Automatic psychic paroxysms

Fish, 1997, Psychic seizures, 543 Devinsky, 1991, Psychic phenomena in partial seizures, Semin Neurol, 11, 100, 10.1055/s-2008-1041211 Wilson, 1928 Penfield, 1954, Sensory seizure-auras, 389 Ey, 1954 Thome-Souza, 2004, Which factors may play a pivotal role on determining the type of psychiatric disorder in children and adolescents with epilepsy, Epilepsy Beba, 5, 988, 10.1016/j.yebeh.2004.09.001 Gaitatzis, 2004, The psychiatric comorbidity of epilepsy, Acta Neurol Scand, 110, 207, 10.1111/j.1600-0404.2004.00324.x Kanner, 2004, Is major depression a neurologic disorder with psychiatric symptoms, Epilepsy Behav, 5, 636, 10.1016/j.yebeh.2004.07.008 Kanner, 2003, Depression in epilepsy is much more than a reactive process, Epilepsy Curr, 3, 202, 10.1046/j.1535-7597.2003.03609.x Gallinat, 2003, Panic attacks, spike-wave activity, and limbic dysfunction. A case report, Pharmacopsychiatry, 36, 123, 10.1055/s-2003-39984 Dantendorfer, 1995, Is there a pathophysiological and therapeutic link between panic disorder and epilepsy, Acta Psychiatr Scand, 91, 430, 10.1111/j.1600-0447.1995.tb09804.x Toni, 1996, Psychosensorial and related phenomena in panic disorder and in temporal lobe epilepsy, Compr Psychiat, 37, 125, 10.1016/S0010-440X(96)90573-8 Ketter, 2003, The diverse roles of anticonvulsants in bipolar disorders, Ann Clin Psychiat, 15, 95, 10.3109/10401230309085675 Goodwin, 2003, Rationale for using lithium in combination with other mood stabilizers in the management of bipolar disorder, J Clin Psychiat, 64, 18 Pies, 2002, Combining lithium and anticonvulsants in bipolar disorder: a review, Ann Clin Psychiat, 14, 223, 10.3109/10401230209147461 Tiihonen, 2004, Lamotrigine treatment for schizophrenia: rationale and outcome, Int J Neuropharmacol, S25 Hosak, 2002, Antiepileptic drugs in schizophrenia: a review, Eur Psychiat, 17, 371, 10.1016/S0924-9338(02)00696-X Winterer, 2000, Valproate and the symptomatic treatment of schizophrenia spectrum patients, Pharmacopsychiatry, 33, 182, 10.1055/s-2000-12981 Markovitz, 2004, Recent trends in the pharmacotherapy of personality disorders, J Personal Disord, 18, 90, 10.1521/pedi.18.1.90.32768 Frankenburg, 2002, Divalproex sodium treatment of women with borderline personality disorder and bipolar II disorder: a double-blind placebo-controlled pilot study, J Clin Psychiat, 63, 442, 10.4088/JCP.v63n0511 Kaufman, 2002, Tiagabine in the management of postencephalitic epilepsy and impulse control disorder, Epilepsy Behav, 3, 190, 10.1006/ebeh.2002.0319 Favale, 2003, The anticonvulsant effect of citalopram as an indirect evidence of serotonergic impairment in human epileptogenesis, Seizure, 12, 316, 10.1016/S1059-1311(02)00315-1 Magyar, 2003, Differential effects of fluoxetine enantiomers in mammalian neural and cardiac tissues, Int J Mol Med, 11, 535 Hernandez, 2002, Effects of fluoxetine and TFMPP on spontaneous seizures in rats with pilocarpine-induced epilepsy, Epilepsia, 43, 1337, 10.1046/j.1528-1157.2002.48701.x Torta, 2002, Atypical antipsychotics and serotoninergic antidepressants in patients with epilepsy: pharmacodynamic considerations, Epilepsia, 10.1046/j.1528-1157.2002.043s2008.x Toczek, 2003, PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy, Neurology, 60, 749, 10.1212/01.WNL.0000049930.93113.20 Pisani, 2002, Effects of psychotropic drugs on seizure threshold, Drug Saf, 25, 91, 10.2165/00002018-200225020-00004 Browning, 1997, Enhancement of the anticonvulsant effect of fluoxetine following blockade of 5-HT1A receptors, Eur J Pharmacol, 336, 1, 10.1016/S0014-2999(97)01215-6 Yang, 2002, Inhibition of Na(+) current by imipramine and related compounds: different binding kinetics as an inactivation stabilizer and as an open channel blocker, Mol Pharmacol, 62, 1228, 10.1124/mol.62.5.1228 Zahorodna, 2002, Imipramine but not 5-HT (1A) receptor agonists or neuroleptics induces adaptive changes in hippocampal 5-HT (1A) and 5-HT (4) receptors, Eur J Pharmacol, 443, 51, 10.1016/S0014-2999(02)01535-2 Sakakihara, 1995, Reduction of seizure frequency with clomipramine in patients with complex partial seizures, Brain Dev, 17, 291, 10.1016/0387-7604(95)00040-I Paul, 1993, Adaptation of the NMDA receptor in rat cortex following chronic electroconvulsive shock or imipramine, Eur J Pharmacol, 247, 305, 10.1016/0922-4106(93)90199-J Cepeda, 1999, Electrophysiological and morphological analyses of cortical neurons obtained from children with catastrophic epilepsy: dopamine receptor modulation of glutamatergic responses, Dev Neurosci, 21, 223, 10.1159/000017402 George, 1997, Dopaminergic modulation of lithium/pilocarpine-induced status epilepticus in rats, Meth Find Exp Clin Pharmacol, 19, 481 Starr, 1996, The role of dopamine in epilepsy, Synapse, 22, 159, 10.1002/(SICI)1098-2396(199602)22:2<159::AID-SYN8>3.0.CO;2-C Krishnamoorthy, 2003, Treatment of depression in patients with epilepsy: problems, pitfalls, and some solutions, Epilepsy Behav, 4, S46, 10.1016/j.yebeh.2003.08.017 Dailey, 1996, Antidepressants and seizures: clinical anecdotes overshadow neuroscience, Biochem Pharmacol, 52, 1323, 10.1016/S0006-2952(96)00509-6 McElroy, 2004, A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression, J Clin Psychiat, 65, 204, 10.4088/JCP.v65n0210 Bowden, 2004, Safety and tolerability of lamotrigine for bipolar disorder, Drug Saf, 27, 173, 10.2165/00002018-200427030-00002 Bowden, 2005, Treatment options for bipolar depression, J Clin Psychiat, 66, 3